Actos Lawsuit News: Appellate Court Reinstates $6.5 Million Jury Award

Actos Lawsuit News: Appellate Court Reinstates $6.5 Million Jury Award

In a significant development in the Actos litigation, the California State Appeals Court for the Second District last week reinstated a cancer patient and spouse’s $6.5 million jury award against the makers of Actos, a diabetes medication. The appellate court’s decision reaffirms the importance and role of the jury in deciding claims.

[Read more…]

Actos Bladder Cancer Lawsuit Video

Actos drug imagePatients who developed bladder cancer after being prescribed the diabetes medication Actos (brand name for the drug pioglitazone) have filed lawsuits against the manufacturer of Actos charging that it did not adequately warn of its cancer risks. Drug makers have a duty to warn of all serious side effects from their medications. These videos discuss the link between Actos and bladder cancer and summarize the charged made in the Actos bladder cancer lawsuits.

[Read more…]